SS Innovations International Inc. (NASDAQ: SSII) is building a strong position in the emerging field of telerobotic surgery, according to a recent MedTech Dive report. The article, titled “Telerobotic surgery is advancing around the world. Will the US embrace it?,” examined the technology’s development and the regulatory and infrastructure questions surrounding remote surgery. It highlighted SS Innovations International (NASDAQ: SSII) alongside larger medical-device companies and emerging robotics developers (https://ibn.fm/4ZLvL).
Dr. Sudhir Srivastava, founder and CEO of SS Innovations and a cardiac surgeon, told MedTech Dive that robotic surgery is inherently a form of teleoperation and that the central technical question is how much distance can be introduced without compromising responsiveness. The company’s SSi Mantra system has been used in 195 robotic telesurgeries as of September 28, 2026, including cardiac procedures and long-distance operations.
The installed base of SSi Mantra systems reached 244 as of September 28, up 45% from the end of 2025. Cumulative procedures performed using the system totaled 14,503. The system has expanded into 12 countries, with recent cardiac-surgery programs launched in Colombia and Sri Lanka and a new program established at HCG Hospital in Ahmedabad. SS Innovations is currently pursuing U.S. FDA clearance and European Union CE marking as it seeks to expand into additional international markets.
For investors, these metrics indicate growing adoption and clinical validation of the SSi Mantra platform. The company’s progress in telesurgery could position it to capture a share of the surgical robotics market as remote procedures gain ground. The pursuit of FDA clearance and CE marking represents key regulatory milestones that could unlock access to the world’s largest healthcare markets.
The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII. For a deeper look at SS Innovations’ telerobotic surgery position, Read More>>.
MissionIR, a specialized communications platform, assists IR firms with syndicated content to enhance the visibility of private and public companies. It is one of 75+ brands within the Dynamic Brand Portfolio at IBN, which delivers wire solutions via InvestorWire, editorial syndication to 5,000+ outlets, and more. For full terms of use, see the MissionIR website at https://www.MissionIR.com/Disclaimer.
